Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.72B |
| 2 |
Meta Platforms (Facebook)
META
|
+$660M |
| 3 |
Micron Technology
MU
|
+$605M |
| 4 |
Mastercard
MA
|
+$497M |
| 5 |
Tesla
TSLA
|
+$495M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 4 |
Lam Research
LRCX
|
+$699M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$681M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.37% |
| 2 | Technology | 4.49% |
| 3 | Healthcare | 2.99% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
MAPS
12651
DELISTED
WM TECHNOLOGY INC A
MAPS
| $17.4K | ﹤0.01% |
26,418
-395,973
| -94% | -$291K |
2024 Q4
5 quarters
|
|
12652
CALL
Dolphin Entertainment
DLPN
$13.4M
| $17.3K | ﹤0.01% |
11,800
-10,300
| -47% | -$16.5K |
2025 Q4
1 quarter
|
|
12653
PUT
Invivyd
IVVD
$242M
| $17.3K | ﹤0.01% |
13,300
-35,700
| -73% | -$65.6K |
2025 Q3
2 quarters
|
|
12654
CollPlant Biotechnologies
CLGN
$6.54M
| $17.2K | ﹤0.01% |
+3,217
| New | +$32.5K |
2026 Q1
0 quarters
|
|
12655
PUT
Heron Therapeutics
HRTX
$66M
| $16.8K | ﹤0.01% |
21,000
-2,300
| -10% | -$2.67K |
2025 Q3
2 quarters
|
|
12656
PUT
Outlook Therapeutics
OTLK
$144M
| $16.6K | ﹤0.01% |
80,800
-837,500
| -91% | -$362K |
2025 Q3
2 quarters
|
|
12657
DSS Inc
DSS
$6.41M
| $16.1K | ﹤0.01% |
+19,443
| New | +$18.8K |
2026 Q1
0 quarters
|
|
12658
CALL
Health Catalyst
HCAT
$132M
| $15.9K | ﹤0.01% |
+12,500
| New | +$23.5K |
2026 Q1
0 quarters
|
|
|
TOUR
12659
PUT
Tuniu
TOUR
$54M
| $15.8K | ﹤0.01% |
2,050
-3,800
| -65% | -$25.9K |
2023 Q4
9 quarters
|
|
12660
CALL
IT Tech Packaging
ITP
$2.43M
| $15.7K | ﹤0.01% |
86,500
+32,900
| +61% | +$6.75K |
2025 Q3
2 quarters
|
|
12661
CALL
Hyperfine
HYPR
$94.8M
| $15.7K | ﹤0.01% |
14,500
-15,600
| -52% | -$17.7K |
2025 Q3
2 quarters
|
|
|
KBSX
12662
FST Corp
KBSX
$64.9M
| $15.7K | ﹤0.01% |
+11,685
| New | +$14.9K |
2026 Q1
0 quarters
|
|
|
PFSA
12663
Profusa Inc
PFSA
$1.02M
| $15.6K | ﹤0.01% |
+308
| New | +$111K |
2026 Q1
0 quarters
|
|
12664
CALL
CXApp
CXAI
$5.45M
| $15.6K | ﹤0.01% |
1,730
+1,472
| +571% | +$18.3K |
2024 Q2
7 quarters
|
|
|
HPAI
12665
Helport AI
HPAI
$11.4M
| $15.5K | ﹤0.01% |
+10,359
| New | +$31K |
2026 Q1
0 quarters
|
|
|
RDHL
12666
Redhill Biopharma
RDHL
$4.44M
| $15.4K | ﹤0.01% |
20,673
+5,196
| +34% | +$5.48K |
2025 Q4
1 quarter
|
|
|
BBBYW
12667
Neighborhood Intelligence Inc Warrants
BBBYW
$2.55M
| $15.3K | ﹤0.01% |
27,187
-5,688
| -17% | -$4.04K |
2025 Q4
1 quarter
|
|
|
ONCY
12668
Oncolytics Biotech
ONCY
$80.5M
| $15.2K | ﹤0.01% |
+17,938
| New | +$17.8K |
2026 Q1
0 quarters
|
|
|
STKE
12669
Sol Strategies Inc
STKE
$67.9M
| $15.2K | ﹤0.01% |
15,421
-53,290
| -78% | -$83.4K |
2025 Q4
1 quarter
|
|
|
SUIG
12670
PUT
Sui Group Holdings
SUIG
$126M
| $14.5K | ﹤0.01% |
12,000
-45,700
| -79% | -$67.7K |
2025 Q3
2 quarters
|
|
|
ACCL
12671
Acco Group Holdings
ACCL
$36.3M
| $14.3K | ﹤0.01% |
10,662
-14,849
| -58% | -$25.8K |
2025 Q4
1 quarter
|
|
|
ABVE
12672
PUT
DELISTED
Above Food Ingredients Inc
ABVE
| $14.2K | ﹤0.01% |
+14,100
| New | +$22.5K |
2026 Q1
0 quarters
|
|
12673
CALL
INmune Bio
INMB
$53.6M
| $14.1K | ﹤0.01% |
12,500
-33,200
| -73% | -$47.3K |
2021 Q2
19 quarters
|
|
12674
CALL
Vivani Medical
VANI
$111M
| $14.1K | ﹤0.01% |
14,100
-30,700
| -69% | -$38.4K |
2025 Q4
1 quarter
|
|
12675
TDH Holdings
PETZ
$13.4M
| $14.1K | ﹤0.01% |
11,732
-37,991
| -76% | -$42.5K |
2025 Q3
2 quarters
|
|
Similar funds
Citadel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citadel Advisors's Q1 2026 filing shows 2,347 new, 5,138 increased, 5,286 reduced and 2,003 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M. The largest sale was Amazon, an estimated $1.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
- Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
- Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
- Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
- Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
- Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.